They Parted On The Best Of Terms

They parted on the best of terms.
   
They also parted friends, even though he felt a sense of injury and hostility toward her.  Who the hell did they think they were?
   
Refreshing to see her so happy for him.
   
He was comfortable right where he was in his chair.
   
He could wait.
   
Their paths crossed again in the kitchen as he was starting away to his studio to sort his mail and consider what to work on next.
   
His passion spent, he was at once exhausted.
   
Sleep was fitful, his morale frayed.  He recalled his conversations in the village that day and questioned his future.  He felt small, humbled, and spoiled.  Dozing off, he had another thought, and this thought was still in his mind when he awoke.
   
Someone must have been telling lies about him.  Without having done anything wrong, Jasper awoke from an uneasy sleep to find himself transformed into a brown beastie carting around something of a hard backed shell on top of him.  With no loss of time and a straw broom, he was battered into the street by his family.
   
Disgusting.  Jasper heard his troll of a parent rage away, determined to brook no contradiction from either of the two women egging him on.  They, his mother and sister, stood crouching in each other’s arms in a corner of the big square foyer, white-faced and appalled.
   
His father snorted.  His father was the one wielding the broom, flourishing at the same time a rolled-up copy of Vogue should Jasper try to scoot back in around him.

Comments

Post a Comment

Popular posts from this blog

Pepsi Buys Rockstar

Pepsi buys Rockstar .     P epsiCo buys Rockstar Energy Beverages for $3.85 billion.     Founded in 2001, Rockstar is drinks designed for people leading an active lifestyle. Available in 20 flavors at convenience and grocery stores in 30 countries. Distributed by PepsiCo in North America since 2009. Supporting the Rockstar lifestyle across the globe through action sports, motorsports, and live music. Pepsi's energy portfolio also includes Kickstart , GameFuel, and Amp Energy.     The deal reflects the shift from reliance on sales of sugary, fizzy drinks toward options ranging from tea and coffee to still and sparkling water varieties, which appeal to health-conscious and younger consumers. Neither PepsiCo nor Coca-Cola owns a major brand in the energy drinks category, which is forecast to grow to more than $80 billion over the next five years and is now dominated by Red Bull.     2 00 countries and territories around the world enjoy ...
Read more

Compass Buys Marucci

Compass buys Marucci.     Compass Diversified Holdings buys Marucci Sports for $200 million.     Marucci Sports was founded in 2009 by Kurt Ainsworth, a retired pitcher for the San Francisco Giants and Baltimore Orioles, Joe Lawrence, a former second baseman for the Toronto Blue Jays, and Reed Dickens, a former White House Assistant Press Secretary under George W. Bush.     Marucci ’s first buy was Marucci Bat Company, launched out of a backyard shed in 2004. Ainsworth then led the buyout of an Amish-run Pennsylvania wood mill in 2008. This solidified Marucci's superior wood supply, and it still supplies all Marucci's wood today. In 2017 Marucci bought Victus , a baseball equipment maker known for its edgy designs and big attitude.     With vertically cohesive wood bat production, a global supplier group, and a client base of MVPs and World Series winners, Marucci and Victus are the top two bats among Big League players. T...
Read more

Gilead Buys Forty Seven

Gilead buys Forty Seven.     Gilead Sciences buys Forty Seven for $4.9 billion.     Forty Seven is a clinical-stage immuno-oncology firm developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches based on tech licensed from Stanford. Forty Seven’s lead program, magrolimab , is a monoclonal antibody against the CD47 receptor, a ‘don’t eat me’ signal that cancer cells commandeer to avoid being ingested by macrophages. Evaluated ant ibodies are in many clinical studies of patients with myelodysplastic syndrome, acute myeloid leukemia, non-Hodgkin lymphoma, and solid tumors. These assets complement the cell therapy franchise Gilead added with its 2017 buy of Kite Pharma .     Beyond magrolimab , Forty Seven is fixing to advance two more compounds into clinical testing. Developing FSI-174, an anti-cKIT antibody, in combination with magrolimab creates a novel, all-antibody conditioning regimen to address ...
Read more